<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients are at increased risk of developing concurrent <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> with <z:mp ids='MP_0001799'>viral</z:mp>, parasitic, fungal or mycobacterial organisms </plain></SENT>
<SENT sid="1" pm="."><plain>They can present constitutional symptoms of <z:hpo ids='HP_0001945'>fever</z:hpo> and <z:hpo ids='HP_0001824'>weight loss</z:hpo>, either due to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> or an underlying <z:hpo ids='HP_0002665'>lymphoma</z:hpo> which may coexist </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: A child with HIV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and mild <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> is reported, who during the course of a confirmed <z:e sem="disease" ids="C0489980" disease_type="Disease or Syndrome" abbrv="">disseminated mycobacterial disease</z:e> developed neurological impairment </plain></SENT>
<SENT sid="3" pm="."><plain>Post-mortem examination revealed disseminated <z:e sem="disease" ids="C0860040" disease_type="Disease or Syndrome" abbrv="">BCG infection</z:e> and Epstein-Barr associated primary <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Epstein-Barr virus (EBV) presence was assessed by LMP-1 protein labelling by immunohistochemistry and in situ hybridisation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) for Epstein-Barr virus-encoded <z:chebi fb="40" ids="33697">RNAs</z:chebi> (EBERs) in formalin-fixed and paraffin-embedded sections </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: BCG vaccination among HIV-1 infected children leads to the risk of disseminated <z:e sem="disease" ids="C0860040" disease_type="Disease or Syndrome" abbrv="">BCG infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>BCG immunization programmes should be reconsidered for children at risk of <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e>, because the risk of delayed complications is independent of the immunological status at the time of the vaccination </plain></SENT>
<SENT sid="7" pm="."><plain>Only <z:hpo ids='HP_0003745'>isolated cases</z:hpo> of primary <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurring in HIV-infected children have been reported, and a striking association with <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> has been demonstrated </plain></SENT>
</text></document>